| COMPANY | Nat Habit, Ayurveda-based hair, skin, body and baby care · founded 2019 by Swagatika Das and Gaurav Agarwal (CB Insights: 2018) |
|---|
| ROUND | Series C ₹142 Cr (US$14.7m per Inc42; US$15–17m elsewhere), all primary · led by Trident Growth Partners · existing Bertelsmann India Investments, Mirabilis Investment Trust, Sharrp Ventures · new: Physis Capital, Hero Family Office |
| EARLIER ROUNDS | Series A about US$4m · Series B US$10.2m (2023, Bertelsmann India Investments; ARR then about ₹82 Cr) |
| SCALE (COMPANY) | Annualised gross revenue ₹330 Cr · about 20,000 stores · 60 lakh+ households |
| PLAN | Target 2 lakh stores in three years · modern trade · quick commerce · Tier 2 and 3 reach · new categories incl. sunscreens and serums · formulation and manufacturing capacity |
| NOT PUBLISHED | Valuation, audited revenue, profit or loss, online-offline split |
| THE ACCESS POINT
Nat Habit is private. No secondary market has been reported. The investors named are Trident Growth Partners, Bertelsmann India Investments, Mirabilis Investment Trust, Sharrp Ventures, Physis Capital and Hero Family Office. |
|---|
Executive decision summary
| THE BOTTOM LINE | Nat Habit raised ₹142 crore in an all-primary Series C in October 2026, led by Trident Growth Partners, with existing investors Bertelsmann India Investments, Mirabilis and Sharrp Ventures and new money from Physis Capital and Hero Family Office. The brand sells Ayurveda-based hair, skin, body and baby care and now reports an annualised gross revenue of ₹330 crore, about four times the ₹82 crore annual recurring revenue it cited in December 2023. Distribution is the plan: about 20,000 stores today, a target of 2 lakh in three years, plus modern trade, quick commerce and smaller cities. What is unpublished is profit, valuation and audited revenue. The ₹330 crore is a gross run-rate, not accounts. |
|---|
| WHICH INVESTOR | Nat Habit fits a watch-list IF you want an Indian Ayurveda personal-care brand scaling through offline distribution.
Wait IF you need audited revenue, margins and a valuation: none was published. |
| COMFORT FIT | Nat Habit = a local Ayurveda shop growing into a chain of shelf-space. Brand first, now 20,000 stores.
2 lakh stores = ten times the current reach in three years. The plan is distribution, not new products.
Gross run-rate = sales before returns and discounts. It is bigger than net revenue.
DailyObjects (Report 10) = another Indian brand using stores to cut paid marketing. |
| THE RUPEIA NUMBER | 10x. Nat Habit's plan to grow from about 20,000 stores to 2 lakh in three years (company plan). |
1 CLAIM REGISTER: EVIDENCE GRADING
| Claim | Source | Grade | Rupeia assessment |
|---|
| ₹142 Cr all-primary Series C led by Trident Growth Partners, 12 Oct 2026 | Entrepreneur India; Digital Terminal; Inc42 (10 Oct) | C | Established |
| Investors: Bertelsmann India Investments, Mirabilis, Sharrp, Physis, Hero Family Office | Entrepreneur India | C | Established |
| Annualised gross revenue ₹330 Cr; about 20,000 stores; 60 lakh households | Entrepreneur India; Inc42; Digital Terminal | B | Company-reported |
| Target 2 lakh stores in three years | Inc42 | B | Company plan |
| Series B US$10.2m (2023); ARR ₹82 Cr at that time | Inc42; India Retailing | C | Established |
| Valuation; audited revenue; profit | Not published | – | Not disclosed |
2 COMPANY, FUNDING AND GROWTH
| Round | Amount | Investors |
|---|
| Series A | About US$4m | Reported in a headline; details not read |
| Series B (2023) | US$10.2m (~₹85 Cr) | Led by Bertelsmann India Investments |
| Series C (Oct 2026) | ₹142 Cr (~US$14.7m) | Trident Growth Partners (lead); Bertelsmann, Mirabilis, Sharrp; new: Physis Capital, Hero Family Office |
| Total (Rupeia sum) | About US$29m | 4 + 10.2 + 14.7 |
| Growth measure (company figures) | Value |
|---|
| ARR, Dec 2023 | ₹82 Cr |
| Annualised gross revenue, Oct 2026 | ₹330 Cr |
| Multiple (Rupeia) | 4.0x in about 34 months, about 52% a year |
| Stores today vs target | 20,000 vs 2 lakh |
| Series C ÷ run-rate | ₹142 Cr ÷ ₹330 Cr = 43% |
Trident's Atul Gupta said "the business has reached an inflection point" and founder Swagatika Das said the ambition is to make products accessible to many more households across India. Funds will go to the product portfolio, quick commerce and offline distribution, digital reach in smaller cities, and formulation and manufacturing; R&D and facilities will support new categories including sunscreens and serums.
| RUPEIA READ
Physis Capital (Report 11) is a new investor in the round. The Series C is 43% of the annual run-rate, a large raise relative to revenue, and it is all primary: no early investor sold. |
|---|
3 DISTRIBUTION MATHS
| Measure (Rupeia calculation, company figures) | Value |
|---|
| Run-rate per store today | ₹330 Cr ÷ 20,000 = ₹1.65 lakh a year (but only part of sales is offline) |
| Store count multiple planned | 2 lakh ÷ 20,000 = 10x in three years |
| Stores to open per month over 36 months | ~5,000 |
| Series C ÷ target stores | ₹142 Cr ÷ 1.8 lakh new stores ≈ ₹7,900 per new store |
| Growth since the 2023 Series B | ARR ₹82 Cr to ₹330 Cr = 4.0x |
| RUPEIA READ
Opening about 5,000 stores a month at ₹7,900 of Series C money each is only plausible through third-party retailers stocking the product, not company-owned outlets. That makes working capital, inventory and distributor credit the main uses of cash beyond the headline plan. |
|---|
4 WHO BACKS THE BRAND
| Investor | Role in the Series C |
|---|
| Trident Growth Partners | Lead |
| Bertelsmann India Investments | Existing; led the 2023 Series B |
| Mirabilis Investment Trust | Existing |
| Sharrp Ventures | Existing |
| Physis Capital (Report 11) | New |
| Hero Family Office | New |
| RUPEIA CALCULATION
Three of the six investors in the Series C are existing backers, which is a sign of insider conviction, and the round is all primary: no early investor sold. Total raised across three rounds is about US$29m (Rupeia sum), against a ₹330 crore gross run-rate. |
|---|
5 REVENUE RECONCILIATION: ₹106 CRORE AND ₹330 CRORE
| Source and measure | Figure |
|---|
| FY24 revenue (Inc42) | ₹73.5 Cr |
| FY25 revenue (Entrackr / Inc42) | ₹106 Cr / ₹109.3 Cr, up 47–49% |
| FY25 net loss (Entrackr) | ₹29 Cr, up 61% from ₹18 Cr |
| FY25 EBITDA margin; ROCE (Entrackr) | –26.8%; –52.4% |
| Annualised gross revenue in the Series C announcement | ₹330 Cr |
| RUPEIA CALCULATION
The ₹330 crore run-rate is about three times FY25 reported revenue (₹330 Cr ÷ ₹109.3 Cr = 3.0x). A run-rate measures a recent period at a gross level, before returns, discounts and taxes, so the two numbers are not directly comparable; but the gap also reflects growth since March 2025 and the fact that FY26 accounts are not yet filed. The loss of ₹29 crore on ₹106 crore of revenue is a 27% net loss margin. |
|---|
| RUPEIA READ
This is the most important correction to the headline numbers: audited revenue was ₹106–109 crore a year earlier and the brand was losing money. The company's Series C story rests on growth since then, and the first FY26 filing will show how much of the ₹330 crore is net revenue. |
|---|
6 INVESTORS AND FUNDING TOTALS
| Item | Published detail |
|---|
| Earlier lead investors (TheKredible via Entrackr) | Peak XV Partners, Fireside Ventures, Whiteboard Capital |
| Total raised before the Series C | About US$13.5–16m, depending on source |
| Series C | ₹142 Cr (about US$14.7m) |
| Total after Series C (Rupeia calculation) | About US$28–31m |
| Brand rename | One report says the brand has rebranded as Breathe Life |
| RUPEIA READ
Funding totals differ because sources count rounds differently. On any reading, the Series C is roughly a third of everything the company has raised, so it is a significant round for Nat Habit. |
|---|
7 KEY TERMS USED IN THIS REPORT
The terms below are used throughout this report. The first table gives the general meaning; the second shows what each term refers to in this transaction.
| Term | Meaning |
|---|
| Primary vs secondary | Primary money goes into the company as new shares; secondary money goes to selling shareholders. |
| Post-money valuation | The company's value immediately after a round, equal to the pre-money value plus new money. |
| Run-rate | A recent period's revenue multiplied up to a year; it is not audited annual revenue. |
| ARR and GMV | Annual recurring revenue is contracted subscription income; gross merchandise value is the total value of goods sold on a platform. |
| Mezzanine finance | Capital that ranks between debt and equity, usually with a higher return than loans. |
| Dilution | The fall in existing holders' percentage when new shares are issued. |
| Term in this report | What it refers to here |
|---|
| Series C | ₹142 Cr, all primary |
| Run-rate | ₹330 Cr annualised gross revenue |
| Modern trade | Organised retail chains |
| Quick commerce | Delivery in minutes through dark stores |
8 RISKS, SCENARIOS AND FINAL VIEW
| Risk | Evidence | Severity | Kill condition |
|---|
| Distribution ambition | 20,000 to 2 lakh stores in three years | HIGH | Store productivity falls |
| Margins unknown | No profit or loss data | MEDIUM | Losses widen with expansion |
| Gross vs net revenue | ₹330 Cr is gross | MEDIUM | Net figure much lower |
| Competition | Crowded Ayurveda and D2C personal care | MEDIUM | Price and promotion pressure |
| Working capital | Wide offline distribution needs inventory | MEDIUM | Cash strain |
| Scenario | What happens | Outcome |
|---|
| Bull | Store network scales; run-rate doubles; margins hold | Series D or IPO path |
| Base | Slower store growth; steady revenue gains | Moderate step-up |
| Bear | Offline productivity disappoints | Flat valuation |
Nat Habit has the numbers and investors of a fast-growing Indian personal-care brand and the disclosure of a private one. Rupeia's view: the 2 lakh-store plan is the thing to watch; revenue per store and the net-to-gross conversion will decide the outcome.
Frequently asked questions
How much did Nat Habit raise?
₹142 crore (about US$14.7 million) in an all-primary Series C announced on 12 October 2026.
Who led the round?
Trident Growth Partners, with Bertelsmann India Investments, Mirabilis Investment Trust, Sharrp Ventures, Physis Capital and Hero Family Office.
What is Nat Habit's revenue?
The company cites an annualised gross revenue of ₹330 crore; audited figures were not published.
How many stores does Nat Habit sell in?
About 20,000, with a target of 2 lakh within three years.
Who founded Nat Habit?
Swagatika Das and Gaurav Agarwal in 2019.
What will Nat Habit do with the money?
Expand products, quick-commerce and offline distribution, smaller-city reach, and formulation and manufacturing.
Source log
Entrepreneur India: Nat Habit raises INR 142 Cr in Series C
Inc42: D2C brand Nat Habit raises ₹142 Cr to scale offline expansion
Digital Terminal: Nat Habit raises ₹142 crore in Series C led by Trident Growth Partners
YourStory: Nat Habit raises ₹142 Cr in Series C led by Trident Growth Partners
DealStreetAsia: Ayurveda-focused Nat Habit raises US$15m led by Trident Growth Partners
India Retailing: Nat Habit raises US$10.2 million in Series B (Dec 2023)
Inc42: Physis Capital closes maiden fund at ₹400 Cr
| DISCLAIMER
This document is published strictly for informational, educational and academic record-keeping purposes. The publisher is not a SEBI Registered Investment Adviser (RIA) or Research Analyst (RA). It does not constitute personal investment advice, a financial recommendation, or an offer or solicitation to buy, sell or subscribe to any securities. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. |
|---|